Stimulant Laxative Plus Stool Softener Docusate Sodium 50 mg and Sennosides 8.6 8.6 mg; 50 mg Tablet, Film Coated, 100-count — NDC 00536-1248-01 package photo

Stimulant Laxative Plus Stool Softener Docusate Sodium 50 mg and Sennosides 8.6 8.6 mg; 50 mg Tablet, Film Coated, 100-count

by RUGBY LABORATORIES · 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0536-1248-01)
NDC 00536-1248-01
🏷️ FDA NDC (as labeled) 0536-1248-01 billing pads the labeler segment with a zero
This package
Contains100-count Cost per ea$0.0303 NADAC Per package$3.03 / 100 tablets Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.1116/unit — full pricing hub ↓
OTC On market Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 0536-1248-01
Product NDC 0536-1248
11-digit billing NDC 00536124801
NCPDP billing unit EA — each (per item)
RxCUI 998740
UNII 3FYP5M0IJX, F05Q2T2JA0
Application # M007
SPL Set ID f5afd8eb-d35d-44ab-897d-1d41c98ca138
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2019-10-22
Route ORAL
Dosage form TABLET, FILM COATED
Substance SENNOSIDES; DOCUSATE SODIUM
GPI-14 46991002770320
GPI class Stimulant Laxative
GCN Seq No 048044
GCN 13483
HICL code 021772
Ingredient (HICL) Sennosides/Docusate Sodium
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name STIMULANT LAXATIVE PLUS TABLET
FDB brand name Stimulant Laxative Plus
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 0536-1248-01 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1248-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Contact laxatives class.

Drug family (ATC) Contact laxatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerRUGBY LABORATORIES
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedOct 2019
Product typeHuman Otc Drug
Portfolio149 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name STIMULANT LAXATIVE PLUS TABLET Ingredient Sennosides/Docusate Sodium
📖 About the active ingredient: Sennosides; Docusate Sodium MedlinePlus · NLM
General information about the ingredient itself — the description of this specific product follows below.

Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Read the full MedlinePlus article ↗
🧪 What is this product?

This is an over-the-counter oral tablet that combines two active ingredients commonly used together to address constipation. Sennosides function as a stimulant laxative that typically works by encouraging bowel movement. Docusate sodium serves as a stool softener, typically used to make stools easier to pass. This product is marketed under the FDA's OTC monograph rules for laxatives and stool softeners.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color red
ShapeRound
ImprintPH32
Size1 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII O7TSZ97GEP
    A mineral compound that serves as a filler and binding agent in tablets and capsules. It adds bulk to the medicine and helps hold ingredients together during manufacturing.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII M28OL1HH48
    Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 3WJQ0SDW1A
    Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
  • UNII 532B59J990
    Polyvinyl alcohol is a synthetic polymer made from plant-derived materials. It's used as a binder to hold ingredients together, a film-former in coatings, and a thickener in liquid formulations.
  • UNII OJ245FE5EU
    Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescroscarmellose sodium, dicalcium phosphate, FD&C Red #40, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium benzoate, talc, titanium dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.030 $3.03 / 100 tablets
Medicaid paysCMS SDUD · 12 mo $0.1116 $11.16 / 100 tablets
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Dec 2021 Jul 2022 Dec 2025 Aug 2026 $0.034 $0.023
▼ Down 8% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Senexon-S 8.6 mg/1; 50 mg 00536-1247-01 RUGBY 100 tablets $0.030 Availability likely
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mgthis 00536-1248-01 RUGBY 100 tablets $0.030 Availability likely
Sennosides, Docusate Sodium 50 mg/1; 8.6 mg 00904-7440-61 Major 10 tablets $0.030 Availability likely
Senna Plus 50 mg/1; 8.6 mg 46122-0625-72 AmerisourceBergen 60 tablets $0.030 Availability likely
Stool Softener Laxative 50 mg/1; 8.6 mg 46122-0669-78 AmerisourceBergen 100 tablets $0.030 Availability likely
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 60687-0622-01 American 100 tablets $0.030 Availability likely
Senna Plus 8.6 mg/1; 50 mg 70000-0520-01 CARDINAL 30 tablets $0.030 Availability likely
Stool Softener plus Stimulant Laxative 8.6 mg/1; 50 mg 70000-0526-01 CARDINAL 100 tablets $0.030 Availability likely
Senna-S 8.6 mg/1; 50 mg 70677-1069-01 STRATEGIC 60 tablets $0.030 Availability likely
Stool Softener 50 mg/1; 8.6 mg 70677-1094-01 Strategic 100 tablets $0.030 Availability likely
Senna S 50 mg/1; 8.6 mg 83324-0135-60 QUALITY 60 tablets $0.030 Availability likely
Stool Softener 50 mg/1; 8.6 mg 83324-0136-01 QUALITY 100 tablets $0.030 Availability likely
Senna-S 50 mg/1; 8.6 mg 70677-1246-01 Strategic 100 tablets $0.032 FDA listed +5%
Colace 50 mg/1; 8.6 mg 67618-0110-10 Atlantis 5 tablets $0.414 Availability likely +1267%
Senokot-S 8.6 mg/1; 50 mg 67618-0310-01 Atlantis 10 tablets $0.414 Availability likely +1267%
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 00363-0827-20 Walgreens 200 tablets FDA listed
Senna S 50 mg/1; 8.6 mg 00363-0883-12 Walgreens 120 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 00363-8550-20 Walgreens 200 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 00363-8780-20 Walgreens 200 tablets Discontinued
Senexon-S 8.6 mg/1; 50 mg 00615-8331-39 NCS 30 tablets FDA listed
Senna-S Laxative With Stool Softener 50 mg/1; 8.6 mg 00761-0910-02 Basic 100 tablets FDA listed
Senna S 8.6 mg/1; 50 mg 10135-0669-01 Marlex 100 tablets FDA listed
Stool Softening Senna Laxative 50 mg/1; 8.6 mg 11673-0192-03 TARGET 30 tablets FDA listed
Stool Softener And Stimulant Laxative 8.6 mg/1; 50 mg 11673-0209-01 TARGET 100 tablets FDA listed
Senna-S 8.6 mg/1; 50 mg 16103-0378-07 Pharbest 60 tablets FDA listed
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 17856-1248-01 ATLANTIC 1 tablet FDA listed
Natural Vegetable Laxative and Stool Softener 50 mg/1; 8.6 mg 21130-0219-03 BETTER 30 tablets FDA listed
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 21130-0829-20 Safeway, 200 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 21130-0855-20 Safeway, 200 tablets FDA listed
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 21130-0878-20 Safeway, 200 tablets FDA listed
Senna S 50 mg/1; 8.6 mg 21130-0883-30 Safeway, 30 tablets FDA listed
Stool Softener 8.6 mg/1; 50 mg 21130-0902-20 BETTER 200 tablets FDA listed
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 36800-0084-01 TOP 100 tablets FDA listed
Senna S 50 mg/1; 8.6 mg 36800-0783-12 TOP 120 tablets FDA listed
Laxative Docusate Sodium with Senna 50 mg/1; 8.6 mg 36800-0861-01 TOPCO 100 tablets FDA listed
Vegetable Laxative and Stool Softner 50 mg/1; 8.6 mg 36800-0938-60 TOPCO 60 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 37808-0355-12 H 120 tablets FDA listed
Stool Softener and Stimulant Laxative 50 mg/1; 8.6 mg 37808-0549-29 H-E-B 240 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 37808-0878-12 H 120 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 41163-0755-10 United 100 tablets FDA listed
Stool Softener Plus Stimulant 50 mg/1; 8.6 mg 41163-0778-10 United 100 tablets FDA listed
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 41163-0829-10 United 100 tablets FDA listed
Senna S 50 mg/1; 8.6 mg 41163-0883-30 United 30 tablets FDA listed
Senna-S 8.6 mg/1; 50 mg 41226-0192-06 KROGER 60 tablets FDA listed
Stool Softener-Stimulant Laxative 8.6 mg/1; 50 mg 41226-0209-06 Kroger 60 tablets FDA listed
Sool Softener Laxative 50 mg/1; 8.6 mg 49035-0270-30 EQUATE 30 tablets FDA listed
Laxative and Stool Softener 50 mg/1; 8.6 mg 49035-0360-30 EQUATE 30 tablets FDA listed
Senna Time S 50 mg/1; 8.6 min 49483-0081-00 TIME 100000 tablets FDA listed
Sennosides And Docusate Sodium 8.6 mg/1; 50 mg 49483-0097-00 TIME 100000 tablets FDA listed
Laxacin 50 mg/1; 8.6 mg 50488-0901-01 Alexso, 100 tablets FDA listed
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 50804-0304-10 GOOD 100 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 50804-0855-10 Good 100 tablets Discontinued
Senna S 50 mg/1; 8.6 mg 53329-0989-62 Medline 60 tablets FDA listed
Drug Mart Vegetable Laxative plus Stool Softener 50 mg/1; 8.6 mg 53943-0153-01 Discount 100 tablets FDA listed
Drug Mart Stool Softener plus Stimulant Laxative 50 mg/1; 8.6 mg 53943-0154-01 Discount 100 tablets FDA listed
Senna S 50 mg/1; 8.6 mg 54257-0089-02 Magno-Humphries, 100 tablets FDA listed
Sennosides, Docusate Sodium 50 mg/1; 8.6 mg 55154-0195-00 Cardinal 10 tablets FDA listed
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 55154-2578-00 Cardinal 10 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 55319-0565-10 Family 100 tablets FDA listed
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0829-10 Dolgencorp, 100 tablets FDA listed
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0855-10 Dolgencorp, 100 tablets FDA listed
Stool Softener Laxative Plus Stimulant 50 mg/1; 8.6 mg 55910-0978-10 Dolgencorp, 100 tablets FDA listed
Stool Softener with Laxative 8.6 mg/1; 50 mg 57896-0304-01 Geri-Care 100 tablets FDA listed
Senna Plus 8.6 mg/1; 50 mg 57896-0458-10 Geri-Care 1000 tablets FDA listed
Senna-Plus 8.6 mg/1; 50 mg 57896-0555-01 Geri-Care 100 tablets FDA listed
Stool Softener with Stimulant Laxative 50 mg/1; 8.6 mg 59726-0855-10 P 100 tablets FDA listed
Stool Softener with Stimulant Laxative 50 mg/1; 8.6 mg 59726-0878-10 P 100 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 62011-0417-01 Strategic 100 tablets Discontinued
Docusate Sodium and Sennosides 50 mg/1; 8.6 mg 62993-0002-01 Morepen 30 tablets FDA listed
Senna-S 8.6 mg/1; 50 mg 63561-0187-01 Granulation 100 tablets FDA listed
Stool Softener Stimulant laxative 50 mg/1; 8.6 mg 63868-0875-01 QUALITY 100 tablets FDA listed
Stool Softener plus Laxative 50 mg/1; 8.6 mg 63868-0878-60 QUALITY 60 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 63868-0884-01 QUALITY 100 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 63868-0946-01 QUALITY 100 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 63941-0855-10 Best 100 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 63941-0878-10 Best 100 tablets FDA listed
Stool Softener with laxative 50 mg/1; 8.6 mg 67091-0328-60 WinCo 60 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 67091-0373-60 WinCo 60 tablets FDA listed
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 68788-7674-01 Preferred 100 tablets FDA listed
Senna-Plus 8.6 mg/1; 50 mg 68788-8780-01 Preferred 100 tablets FDA listed
Senna-S 8.6 mg/1; 50 mg 69517-0131-02 HealthLife 2 tablets FDA listed
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 69618-0065-01 Reliable-1 100 tablets FDA listed
Colon Detox 50 mg/1; 8.6 mg 69729-0151-60 OPMX 60 tablets FDA listed
Laxative Stool Softener 50 mg/1; 8.6 mg 69842-0776-18 CVS 180 tablets FDA listed
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 69842-0881-10 CVS 100 tablets FDA listed
Senna Plus 50 mg/1; 8.6 mg 69842-0883-18 CVS 180 tablets FDA listed
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 69842-0887-10 CVS 100 tablets FDA listed
Docuzen 8.6 mg/1; 50 mg 71205-0282-30 Proficient 30 tablets FDA listed
Senna-S 8.6 mg/1; 50 mg 71205-0970-00 Proficient 100 tablets FDA listed
Senna-Plus 8.6 mg/1; 50 mg 71335-1674-01 Bryant 30 tablets FDA listed
Stool Softener with Laxative 8.6 mg/1; 50 mg 71335-2522-01 Bryant 30 tablets FDA listed
Stimulant Laxative Plus Stool Softener 8.6 mg/1; 50 mg 71335-2693-01 Bryant 30 tablets FDA listed
Docuzen 8.6 mg/1; 50 mg 71574-0700-60 Village 60 tablets FDA listed
Senna-S 50 mg/1; 8.6 mg 72090-0030-20 Pioneer 200 tablets FDA listed
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 72476-0855-10 Care 100 tablets FDA listed
Stool Softener Plus Stimulant Laxative 50 mg/1; 8.6 mg 72476-0878-10 Care 100 tablets FDA listed
Senna S Orange 50 mg/1; 8.6 mg 72476-0883-60 Care 60 tablets FDA listed
Senna-S 8.6 mg/1; 50 mg 73057-0378-07 Ulai 60 tablets FDA listed
Sennosides and Docusate Sodium 8.6 mg/1; 50 mg 76420-0918-01 Asclemed 100 tablets FDA listed
Stool Softener plus Stimulant Laxative 8.6 mg/1; 50 mg 79481-0304-01 Meijer, 100 tablets FDA listed
Senna-S 8.6 mg/1; 50 mg 79481-0555-06 Meijer, 60 tablets FDA listed
Stool Softener Laxative 50 mg/1; 8.6 mg 79903-0009-12 WALMART 120 tablets FDA listed
Senna-Plus 50 mg/1; 8.6 mg 80136-0555-01 Heartland 100 tablets Discontinued
Laxacin 50 mg/1; 8.6 mg 80425-0345-01 Advanced 100 tablets FDA listed
Senna-S 8.6 mg/1; 50 mg 80513-0105-25 Advanced 250 tablets FDA listed
Senna With Docusate Sodium 8.6 mg/1; 50 mg 83586-0001-00 HHH 50000 tablets FDA listed
Senna-S 50 mg/1; 8.6 mg 84324-0013-01 NUVICARE 100 tablets FDA listed
Senna-S 8.6 mg/1; 50 mg 85111-0455-10 RMT 1000 tablets FDA listed
Healix Senna-S 8.6 mg/1; 50 mg 87275-2451-01 Brainstorm 100 tablets FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2019
On the market since
Oct 2019
📍
2026
Currently FDA-listed
7 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00536-1248-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
92.8K
Units reimbursed last 4 qtrs
5.3M
Gross reimbursed last 4 qtrs
$589K
Avg / prescription
$6.35
Avg / unit
$0.1116
Latest quarter Q4 2025
26.8KRx
Medicaid pays / ea
$0.1116
gross reimbursed
vs
NADAC / ea
$0.0303
acquisition cost
=
Spread
+$0.0813
+268% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
44% FFS 56% MCO
Fee-for-service · 40,949 Rx Managed care · 51,839 Rx
State Medicaid map
Alaska: no data reported AK Maine: 108,383 units · 7,769 per 100k residents ME Washington: no data reported WA Idaho: no data reported ID Montana: 22,970 units · 2,029 per 100k residents MT North Dakota: no data reported ND Minnesota: 808,883 units · 14,099 per 100k residents MN Wisconsin: 18,021 units · 305 per 100k residents WI Michigan: 289,649 units · 2,886 per 100k residents MI New York: 888,708 units · 4,541 per 100k residents NY Vermont: 27,784 units · 4,294 per 100k residents VT New Hampshire: 11,668 units · 832 per 100k residents NH Oregon: 107,085 units · 2,530 per 100k residents OR Nevada: 39,500 units · 1,237 per 100k residents NV Wyoming: 2,350 units · 402 per 100k residents WY South Dakota: no data reported SD Iowa: 87,671 units · 2,734 per 100k residents IA Illinois: 246,735 units · 1,966 per 100k residents IL Indiana: 148,771 units · 2,168 per 100k residents IN Ohio: 276,453 units · 2,346 per 100k residents OH Pennsylvania: 140,832 units · 1,087 per 100k residents PA New Jersey: 84,929 units · 914 per 100k residents NJ Massachusetts: 162,165 units · 2,316 per 100k residents MA California: 377,842 units · 970 per 100k residents CA Utah: 52,851 units · 1,547 per 100k residents UT Colorado: no data reported CO Nebraska: 86,289 units · 4,362 per 100k residents NE Missouri: 288,575 units · 4,657 per 100k residents MO Kentucky: 188,459 units · 4,164 per 100k residents KY West Virginia: no data reported WV Virginia: 74,480 units · 855 per 100k residents VA Maryland: 27,973 units · 453 per 100k residents MD Connecticut: 125,518 units · 3,470 per 100k residents CT Rhode Island: 121,442 units · 11,091 per 100k residents RI Arizona: 119,224 units · 1,604 per 100k residents AZ New Mexico: no data reported NM Kansas: 78,698 units · 2,677 per 100k residents KS Arkansas: no data reported AR Tennessee: 1,451 units · 20.4 per 100k residents TN North Carolina: no data reported NC South Carolina: 13,769 units · 256 per 100k residents SC Delaware: 34,362 units · 3,333 per 100k residents DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 3,927 units · 35.6 per 100k residents GA D.C.: 75,702 units · 11,149 per 100k residents DC Hawaii: 132,759 units · 9,251 per 100k residents HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
20.414,099
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Minnesota 14,099 /100k
2 D.C. 11,149 /100k
3 Rhode Island 11,091 /100k
4 Hawaii 9,251 /100k
5 Maine 7,769 /100k
6 Missouri 4,657 /100k
7 New York 4,541 /100k
8 Nebraska 4,362 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1000 tablets00536-1248-10 172,190 Rx · $1,200,004
100 tablets this page00536-1248-01 92,788 Rx · $589,010
Drug total (last 4 qtrs): 264,978 Rx · 14,460,255 units · $1,789,014 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Stimulant Laxative Plus Stool Softener (this brand).

Top reported reactions

Death6
Disease Progression4
Vomiting4
Constipation3
Diarrhoea3
Dyspnoea3
Headache3

Reporter sex

38 reports
Male · 42%
Female · 58%

Serious outcomes

Death8
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 17 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
00536-1248-01 You're viewing this 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0536-1248-01) $0.0303 / ea $3.03 2019-10-22 Active
00536-1248-10 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0536-1248-10) $0.0303 / ea $30.28 2019-10-22 Active

You're viewing the smallest of 2 pack sizes for this product.

This pack has the lowest per-ea cost of the 2 priced pack sizes ($0.0303 NADAC).

This pack accounts for about 35% of this product's recent Medicaid fills; most go to the 1000 tablets pack. See all packs ↓

Pack size FAQ

What quantity is in NDC 00536-1248-01?
NDC 00536-1248-01 is a 100-count package — 100 tablet, film coated in 1 bottle, plastic.
What is the difference between NDC 00536-1248-01 and NDC 00536-1248-10?
Both are Stimulant Laxative Plus Stool Softener Docusate Sodium 50 mg and Sennosides 8.6 8.6 mg; 50 mg Tablet, Film Coated — the drug itself is identical. NDC 00536-1248-01 is the 100-count package, while NDC 00536-1248-10 is the 1000 tablets package.
What NDC number is used to bill for this package of Stimulant Laxative Plus Stool Softener Docusate Sodium 50 mg and Sennosides 8.6 8.6 mg; 50 mg Tablet, Film Coated?
Bill NDC 00536-1248-01 — the 11-digit billing format is 00536124801. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 15 words

Uses relieves occasional constipation (irregularity) generally produces a bowel movement in 6 to 12 hours

⏱️ Dosage and Administration 64 words

Directions take only by mouth. Doses may be taken as a single daily dose, preferably in the evening, or in divided doses adults and children 12 years and over take 2-4 tablets daily children 6 to under 12 years of age take 1-2 tablets daily children 2 to under 6 years of age take upto 1 tablet daily children under 2 ask a doctor

⚠️ Warnings 122 words

Warnings Do not use laxative products for longer than 1 week unless told to do so by a doctor if you are presently taking mineral oil, unless told to do so by a doctor Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel habits that lasts over 2 weeks Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after the use of a laxative. These could be sings of a serious condition. If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

📦 Storage and Handling 30 words

Other information each tablet contains: calcium 10 mg, sodium 5 mg, Very Low Sodium store at 20-25°C (68-77°F); excursions permitted between 15-30 o C (59-86 o F). Keep tightly closed.

🧪 Active Ingredient 12 words

Active Ingredients (in each tablet) Docusate Sodium 50 mg Sennosides 8.6 mg

🧪 Inactive Ingredients 22 words

Inactive ingredients croscarmellose sodium, dicalcium phosphate, FD&C Red #40, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, sodium benzoate, talc, titanium dioxide

🎯 Purpose 5 words

Purpose Stool softener Stimulant laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.